TR200401848T4 - Uzun süreli levodopa ve karbidopa bırakılması içeren kompozisyon. - Google Patents
Uzun süreli levodopa ve karbidopa bırakılması içeren kompozisyon.Info
- Publication number
- TR200401848T4 TR200401848T4 TR2004/01848T TR200401848T TR200401848T4 TR 200401848 T4 TR200401848 T4 TR 200401848T4 TR 2004/01848 T TR2004/01848 T TR 2004/01848T TR 200401848 T TR200401848 T TR 200401848T TR 200401848 T4 TR200401848 T4 TR 200401848T4
- Authority
- TR
- Turkey
- Prior art keywords
- carbidopa
- levodopa
- composition containing
- term release
- containing long
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Bulus, terapötik olarak etkili miktarda levodopa ve karbidopa içeren, hidrofilik bir matris içinde dagilmis bir farmasötik kompozisyonla ilgilidir, sözü edilen kompozisyon bir organik asit içerir. Bulus ayrica kompozisyonu hazirlamak için bir islemle ilgilidir, islem; özellikle sivilastirilmis bir yatakta çesitli bilesenlerin granülasyonu ve elde edilen taneciklerin sikistirilmasini içerir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/866,857 US6531153B2 (en) | 2001-05-29 | 2001-05-29 | Composition with sustained release of levodopa and carbidopa |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200401848T4 true TR200401848T4 (tr) | 2004-09-21 |
Family
ID=25348578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/01848T TR200401848T4 (tr) | 2001-05-29 | 2002-05-17 | Uzun süreli levodopa ve karbidopa bırakılması içeren kompozisyon. |
Country Status (8)
Country | Link |
---|---|
US (1) | US6531153B2 (tr) |
EP (1) | EP1262198B1 (tr) |
AT (1) | ATE265231T1 (tr) |
DE (1) | DE60200416T2 (tr) |
DK (1) | DK1262198T3 (tr) |
ES (1) | ES2222436T3 (tr) |
PT (1) | PT1262198E (tr) |
TR (1) | TR200401848T4 (tr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
AU2003214551A1 (en) * | 2002-04-11 | 2003-10-20 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical compositions of carbidopa and levodopa |
AU2003260200A1 (en) * | 2002-09-03 | 2004-03-29 | Universite Libre De Bruxelles | Reversible, parallel and multitask cloning method and kit |
US20070009596A1 (en) * | 2003-05-14 | 2007-01-11 | Bruschi Stefano D L | Controlled drug release composition resistant to in vivo mechanic stress |
US8815950B2 (en) | 2003-08-29 | 2014-08-26 | Janssen Biotech, Inc. | Pharmaceutical compositions and method of using levodopa and carbidopa |
JP5160786B2 (ja) * | 2003-08-29 | 2013-03-13 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 医薬組成物及びレボドパ及びカルビドパの使用方法 |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
RU2440100C2 (ru) * | 2005-03-28 | 2012-01-20 | Орексо Аб | Новые фармацевтические композиции, полезные в лечении болезни паркинсона |
EP1901720A2 (en) * | 2005-06-23 | 2008-03-26 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
AR055106A1 (es) * | 2005-08-05 | 2007-08-08 | Osmotica Pharmaceutical Argent | Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa |
EP1945188A2 (en) * | 2005-11-07 | 2008-07-23 | Teva Pharmaceutical Industries Ltd. | Levodopa compositions |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
WO2008030830A2 (en) * | 2006-09-08 | 2008-03-13 | Drugtech Corporation | Sustained-release composition and method of use thereof |
WO2008079404A2 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
ATE549438T1 (de) * | 2007-01-10 | 2012-03-15 | Crystal Systems Corp | Vorrichtung zum tiegelfreien zonenschmelzen |
US20090155369A1 (en) * | 2007-12-13 | 2009-06-18 | Laboratorios Lesvi, S.L. | Pharmaceutical composition containing levodopa, entacapone and carbidopa |
AU2014202306B2 (en) * | 2007-12-28 | 2016-09-08 | Impax Laboratories, Llc | Controlled release formulations of levodopa and uses thereof |
AU2008343787B2 (en) | 2007-12-28 | 2014-01-30 | Impax Laboratories, Llc | Controlled release formulations of levodopa and uses thereof |
DE102008004893A1 (de) * | 2008-01-17 | 2009-07-23 | Add Technologies Ltd. | Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung |
WO2010019915A1 (en) | 2008-08-15 | 2010-02-18 | Depomed Inc. | Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders |
TR201204839A2 (tr) | 2012-04-25 | 2012-12-21 | Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. | Uzatılmış salım sağlayan levodopa karbıdopa entakapon içeren tablet formülasyonu. |
WO2014074797A1 (en) | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
US8545878B1 (en) * | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
US10098845B2 (en) | 2013-10-07 | 2018-10-16 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
US10588863B2 (en) | 2017-06-16 | 2020-03-17 | Kashiv Biosciences, Llc | Extended release compositions comprising pyridostigmine |
CA3031412C (en) | 2017-06-16 | 2020-08-11 | Kashiv Pharma Llc | Gastroretentive dosage forms for sustained drug delivery |
US10987311B2 (en) | 2017-06-16 | 2021-04-27 | Kashiv Specialty Pharmaceuticals, Llc | Extended release compositions comprising pyridostigmine |
JP7066351B2 (ja) * | 2017-08-18 | 2022-05-13 | 大原薬品工業株式会社 | 良好な徐放性を有する、レボドパ含有小型化錠剤 |
EP3824881B1 (en) | 2018-06-18 | 2022-02-16 | Amneal Complex Products Research LLC | Extended release compositions comprising pyridostigmine |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4424235A (en) | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
NZ220599A (en) * | 1986-06-16 | 1990-10-26 | Merck & Co Inc | Controlled release oral dosage formulation of carbidopa and levodopa |
US5190763A (en) * | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
DE4101873C2 (de) | 1991-01-23 | 1993-12-09 | Isis Pharma Gmbh | Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände |
US5354885A (en) * | 1992-12-24 | 1994-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Process for preparing ethyl ester of L-DOPA |
IT1293764B1 (it) | 1997-07-23 | 1999-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua |
-
2001
- 2001-05-29 US US09/866,857 patent/US6531153B2/en not_active Expired - Lifetime
-
2002
- 2002-05-17 DK DK02291229T patent/DK1262198T3/da active
- 2002-05-17 TR TR2004/01848T patent/TR200401848T4/tr unknown
- 2002-05-17 EP EP02291229A patent/EP1262198B1/en not_active Expired - Lifetime
- 2002-05-17 AT AT02291229T patent/ATE265231T1/de active
- 2002-05-17 DE DE60200416T patent/DE60200416T2/de not_active Expired - Lifetime
- 2002-05-17 ES ES02291229T patent/ES2222436T3/es not_active Expired - Lifetime
- 2002-05-17 PT PT02291229T patent/PT1262198E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
PT1262198E (pt) | 2004-09-30 |
ES2222436T3 (es) | 2005-02-01 |
DE60200416T2 (de) | 2005-03-03 |
US20020192290A1 (en) | 2002-12-19 |
EP1262198A1 (en) | 2002-12-04 |
ATE265231T1 (de) | 2004-05-15 |
DE60200416D1 (de) | 2004-06-03 |
DK1262198T3 (da) | 2004-08-16 |
EP1262198B1 (en) | 2004-04-28 |
US6531153B2 (en) | 2003-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200401848T4 (tr) | Uzun süreli levodopa ve karbidopa bırakılması içeren kompozisyon. | |
BR0110703A (pt) | Amida, composição farmacêutica que compreende um composto, compostos, utilização de compostos, processos para o tratamento profilático ou terapêutico de diabetes do tipo ii e para a preparação desses compostos | |
TR200200688T2 (tr) | Doğrudan tablet şeklinde preslenebilen ultra ince asetaminofen terkipleri ve bu terkiplerin üretim prosesi | |
SE9301489D0 (sv) | Veterinary composition | |
HK1068282A1 (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease | |
DK0560092T3 (da) | Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer | |
IN2014DN07624A (tr) | ||
BRPI0414893A (pt) | corpos miméticos de núcleo de articulação mimética de epo humanos, composições, métodos e usos | |
UA81676C2 (ru) | Композиция для лечения инфекций у крупного рогатого скота и свиней | |
AU1255002A (en) | Delayed-release pharmaceutical formulations | |
FI925787A (fi) | Proteolytiska enzymers sackarinderivatinhibitorer | |
FR2780052B1 (fr) | Agglomerats a base de charbon actif leur procede de preparation et leur utilisation comme agents d'adsorption | |
UY26256A1 (es) | Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación | |
TW270085B (tr) | ||
EE200400031A (et) | Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat | |
BR9809117A (pt) | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada | |
EA200400072A1 (ru) | Твердая композиция, содержащая споры непатогенных бактерий рода bacillus | |
ATE315395T1 (de) | Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten | |
DE3883098D1 (de) | Spruehgetrocknete ibuprofen-zusammensetzungen. | |
TNSN93008A1 (fr) | Procede de reduction de la teneur en formaldehyde de formulations microencapsulees | |
CA2480429A1 (en) | Novel therapeutical use of agonist ligands specific to g2a receptor | |
ITMI20022394A1 (it) | Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche. | |
BR0008739A (pt) | Composições de liberação controlada debeta-histina | |
PT1171111E (pt) | Granulado com teor elevado de l-carnitina ou de uma alcanoil l-carnitina particularmente adequado para a producao de comprimidos por compressao directa | |
DE60220551D1 (de) | Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid |